The mass manufacture of biofuels could hold the key to greener, more environmentally sound energy, transportation and product options. Scientists have previously engineered metabolic pathways of microbes, making them tiny biofuel factories. Now, new research from an engineer at Washington University in St. Louis further refines the process, stitching together the best bits of several different bacteria to synthesize a new biofuel product that matches current engines better than previously produced biofuels.
An engineering team at Washington University in St. Louis is using E. coli to manufacture biofuel. New research from the lab further refines the process.
“My lab is interested in developing microbial biosynthetic processes to make biofuels, chemicals, and materials with tailored structures and properties,” said Fuzhong Zhang, associate professor at the School of Engineering & Applied Science. “Previously, we engineered E.coli to produce a precursor compound that leads to the production of advanced biofuels. In this work, we took the next step toward the actual manufacture.”
Zhang’s research focuses on engineering metabolic pathways that, when optimized, allow the bacteria to act as a biofuel generator. In its latest findings, recently published in Biotechnology for Biofuels, Zhang’s lab used the best bits of several other species — including a well-known pathogen — to enable E.coli to produce branched, long-chain fatty alcohol (BLFL), a substance that can be used as a freeze-resistant, liquid biofuel.
“We designed and then constructed a synthetic metabolic pathway inside the fast-growing E.coli by introducing genes from other species, including Staphylococus aureus, cyanobacteria and soil bacteria,” Zhang said. “By using CRISPR, we incorporated genes from different species with favorable traits into E.coli’s fatty acid pathway.”
Zhang and his team determined that staph was particularly helpful to solve a common problem when manufacturing biofuel: The virulent pathogen was able to incorporate branches into its lipid. These branch structures dramatically lower the melting temperature of lipids and transform long-chain fatty alcohol from a waxy substance to a liquid that can be better used as a fuel under cold weathers.
Integrating the different species’ genes into E.coli also yielded another result: Normally, E.coli cannot produce any branched lipid on its own, but with the engineered metabolic pathway, 75 percent of the E. coli produced biofuels is branched.
Zhang says the next step involves moving the engineered metabolic pathway into a more industrial-relevant microbial host. His lab is current working with other Washington University labs towards this goal.
Wen Jiang, James B. Qiao, Gayle J. Bentley, Di Liu, Fuzhong Zhang “Modular pathway engineering for the microbial production of branched-chain fatty alcohols” Biotechnology for Biofuels, Oct. 27, 2017
This work was supported by the Defense Advanced Research Projects Agency grant D13AP00038 and National Science Foundation grant MCB1453147. The Zhang research team filed a patent on this work with assistance from the university’s Office of Technology Management.
The School of Engineering & Applied Science at Washington University in St. Louis focuses intellectual efforts through a new convergence paradigm and builds on strengths, particularly as applied to medicine and health, energy and environment, entrepreneurship and security. With 94 tenured/tenure-track and 28 additional full-time faculty, 1,300 undergraduate students, 1,200 graduate students and 20,000 alumni, we are working to leverage our partnerships with academic and industry partners — across disciplines and across the world — to contribute to solving the greatest global challenges of the 21st century.